Author

John T. Given

Observed names: Given, John, J. Given, JOHN GIVEN, John Given

OpenAlex ID: A5062440472

Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma

2000 · GAIL SHAPIRO, WILLIAM LUMRY, et al. · American Journal of Respiratory and Critical Care Medicine · 200

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis

2007 · Harold B. Kaiser, Robert M. Naclerio, et al. · Journal of Allergy and Clinical Immunology · 150

Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

2010 · John T. Given, Amarjit S. Cheema, et al. · American Journal of Rhinology and Allergy · 22

Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis

2020 · Stanley J. Szefler, Stanley Goldstein, et al. · Pulmonary Therapy · 14

Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter

2016 · John Given, Herminia Taveras, et al. · Allergy and Asthma Proceedings · 13

Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter

2012 · John Given, Herminia Taveras, et al. · Allergy and Asthma Proceedings · 13

Efficacy and Safety of Fluticasone Propionate Hydrofluoroalkane Inhalation Aerosol in Four- to Eleven-Year-Old Children with Asthma: A Randomized, Double-Blinded, Placebo-Controlled Study

2006 · Arden L. Levy, John T. Given, et al. · Pediatric Asthma Allergy & Immunology · 4

Safety of fluticasone propionate HFA in treating children 4-11 years of age with asthma

2004 · J. Given, E. Kent, et al. · Journal of Allergy and Clinical Immunology · 4

Once-daily Fluticasone Furoate∗ Nasal Spray (FFNS) is Effective for the Treatment of Seasonal Allergic Rhinitis (SAR) Caused by Ragweed ∗USAN-approved name

2007 · H.B. Kaiser, R. Naclerio, et al. · Journal of Allergy and Clinical Immunology · 3

Once-Daily Fluticasone Furoate∗ Nasal Spray (FFNS) 110mcg Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the ragweed season ∗USAN approved name

2007 · J. Given, T. Toler, et al. · Journal of Allergy and Clinical Immunology · 3

Inclusion of steps to enhance mucus clearance may provide benefit for symptomatic COVID patients by reducing total viral load, time to recovery, risk of complications and transmission risk

2021 · John Given, Charles Steele · Journal of Respiratory Diseases and Medicine

Nasal High Flow (nhf) Therapy Reduces Prednisone Dosing for Women With Uncontrolled Asthma

2019 · John Given · CHEST Journal

Improved Perception of Mucus Clearance and Benefit After Nasal High Flow Therapy in Women with COPD and Asthma

2019 · J. Given, R. Troyer, et al. · American Journal of Respiratory and Critical Care Medicine

A Prospective, Open-Label Assessment Of ProAir® HFA Metered-Dose Inhaler With A New Integrated Dose Counter

2012 · John T. Given, Paul Dorinsky, et al. · American Journal of Respiratory and Critical Care Medicine

Patient Satisfaction With ProAir® HFA MDI With A New Integrated Dose Counter

2012 · John T. Given, Paul Dorinsky, et al. · American Journal of Respiratory and Critical Care Medicine

Once-Daily Fluticasone Furoate Nasal Spray 110 mcg Improves Quality of Life in Subjects with Perennial Allergic Rhinitis

2008 · J. Given, M. White, et al. · Journal of Allergy and Clinical Immunology

Sensitivity of the lung to oxidants cells of the lower respiratory tract are relatively deficient in scavengers of hydrogen per oxide

1983 · André M. Cantin, G A Fells, et al. · American Review of Respiratory Disease

Works count: 18

Citation count: 426

H-index: 6

I10-index: 6